Oramed Pharmaceuticals Inc. (ORMP.TA)
ILA 879.9
(4.22%)
ILA 879.9
(4.22%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -100.99 Million | -67.85 Million | -41.69 Million | -45.68 Million | -52.75 Million | -20.91 Million |
| Net Income | -128.65 Million | -71.24 Million | -38.58 Million | -50.68 Million | -45.8 Million | -37.58 Million |
| Depreciation & Amortization | -204.1 Thousand | -246.68 Thousand | -23.46 Thousand | -28.24 Thousand | -21.59 Thousand | -17.93 Thousand |
| Deferred income taxes | -44.37 Million | -22.97 Million | -4.01 Million | -2.99 Million | -5.89 Million | -5.86 Million |
| Stock-based compensation | 40.54 Million | 21.05 Million | 4.05 Million | 3.05 Million | 5.93 Million | 5.9 Million |
| Change in working capital | -3.31 Million | -4.21 Million | -10.58 Million | 1.02 Million | -12.97 Million | 10.3 Million |
| Other non-cash items | -9.36 Million | -13.21 Million | 3.43 Million | 946.61 Thousand | 112.66 Thousand | 484.97 Thousand |
| Investing Cash Flow | 106.31 Million | -71.32 Million | 15.5 Million | 39.75 Million | -25.21 Million | 15.42 Million |
| Investments in PPE | -1.74 Million | -1.2 Million | -274.84 Thousand | -52.96 Thousand | -17.99 Thousand | -25.1 Thousand |
| Acquisitions | 84.45 Thousand | 4.8 Million | - | - | - | - |
| Investment purchases | -543.35 Million | -172.43 Million | -131.99 Million | -93.02 Million | -95.63 Million | -88.43 Million |
| Sales/Maturities of investments | 651.32 Million | 97.5 Million | 147.78 Million | 147.8 Million | 70.45 Million | 103.89 Million |
| Other Investing Activities | 7038.04 | -3203.75 | -3351.75 | -14.97 Million | -7198.80 | -10.75 Thousand |
| Financing Cash Flow | 40.68 Million | 324.83 Million | 79.72 Million | -360.35 Thousand | 81.54 Million | 5.68 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.75 Million | - | - | - | - | - |
| Common Stock Issuance | 40.68 Million | 324.83 Million | 79.72 Million | - | 81.54 Million | 5.68 Million |
| Other Financing Activities | 2.75 Million | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.32 Million | 6.59 Million | -2.73 Million | 1.76 Million | -2.2 Million | 4.5 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.99 Million | -10.81 Million | -7.84 Million | -744.98 Thousand | -10.76 Million | 5.79 Million |
| Cash at beginning of period | 247.74 Million | 64.72 Million | 11.76 Million | 18.01 Million | 14.22 Million | 14.75 Million |
| Cash at end of period | 142.27 Million | 247.74 Million | 64.72 Million | 11.76 Million | 18.01 Million | 14.22 Million |
| Capital Expenditure | -1.74 Million | -1.2 Million | -274.84 Thousand | -52.96 Thousand | -17.99 Thousand | -25.1 Thousand |
| Effect of forex changes on cash | -225.03 Thousand | 83.78 Thousand | -16.77 Thousand | 49.48 Thousand | 122.58 Thousand | 17.92 Thousand |
| Net cash flow / Change in cash | -105.46 Million | 183.02 Million | 52.95 Million | -6.24 Million | 3.78 Million | -530.28 Thousand |
| Free Cash Flow | -102.74 Million | -69.06 Million | -41.97 Million | -45.74 Million | -52.77 Million | -20.93 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.3 Million | -4.43 Million | -12.23 Million | -128.65 Million | -30.06 Million | -25.15 Million |
| Depreciation & Amortization | -194.55 Thousand | -187.84 Thousand | -133.37 Thousand | -204.1 Thousand | -56.61 Thousand | -51.1 Thousand |
| Deferred income taxes | -7.46 Million | -6.51 Million | -1.13 Million | -44.37 Million | -7.76 Million | -10.64 Million |
| Stock-based compensation | 8.3 Million | 6.74 Million | 622.29 Thousand | 40.54 Million | 9.03 Million | 11.45 Million |
| Change in working capital | 6.96 Million | -11.81 Million | -2.94 Million | -3.31 Million | -5.27 Million | 8.48 Million |
| Other non-cash items | -4.85 Million | 400.41 Thousand | -5.31 Million | -9.36 Million | -464.16 Thousand | -2.32 Million |
| Investing Cash Flow | -276.31 Million | -52.97 Million | -47.59 Million | 106.31 Million | 37.69 Million | 3.75 Million |
| Investments in PPE | -105.47 Thousand | -61.21 Thousand | -717.34 Thousand | -1.74 Million | -1.03 Million | -416.22 Thousand |
| Acquisitions | 286.43 Million | 54.44 Million | 46.77 Million | 84.45 Thousand | 81.31 Thousand | - |
| Investment purchases | -368.4 Million | -258.06 Million | -68.49 Million | -543.35 Million | -133.48 Million | -21.89 Million |
| Sales/Maturities of investments | 92.19 Million | 205.15 Million | 21.61 Million | 651.32 Million | 172.13 Million | 26.06 Million |
| Other Investing Activities | - | - | - | 7038.04 | -3460.09 | -83.61 |
| Financing Cash Flow | 275.69 Million | -145.05 Thousand | 8.75 Million | 40.68 Million | 13.96 Million | 15.18 Million |
| Debt repayment | -275.84 Million | - | - | - | - | - |
| Dividends payments | -284.35 Million | - | - | - | - | - |
| Common Stock Repurchased | -7629.00 | - | - | -2.75 Million | - | -377.98 Thousand |
| Common Stock Issuance | -150.89 Thousand | -145.05 Thousand | 8.75 Million | 40.68 Million | 13.96 Million | 15.18 Million |
| Other Financing Activities | 7629.00 | - | - | 2.75 Million | - | 377.98 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 6.58 Million | -11.78 Million | -371.29 Thousand | -1.32 Million | -147.93 Thousand | 2.53 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 380.05 Thousand | -34.19 Thousand | -2.57 Million | -1.99 Million | -5.12 Million | 5.95 Million |
| Cash at beginning of period | 25.08 Million | 86.7 Million | 142.27 Million | 247.74 Million | 118.37 Million | 104.4 Million |
| Cash at end of period | 20.85 Million | 25.08 Million | 86.7 Million | 142.27 Million | 142.27 Million | 118.37 Million |
| Capital Expenditure | -105.47 Thousand | -61.21 Thousand | -717.34 Thousand | -1.74 Million | -1.03 Million | -416.22 Thousand |
| Effect of forex changes on cash | -118.24 Thousand | 25.94 Thousand | -136.68 Thousand | -225.03 Thousand | -369.2 Thousand | 10.69 Thousand |
| Net cash flow / Change in cash | -4.22 Million | -61.62 Million | -55.57 Million | -105.46 Million | 23.9 Million | 13.96 Million |
| Free Cash Flow | -2.19 Million | -9.35 Million | -20.72 Million | -102.74 Million | -27.85 Million | -8.01 Million |
603316
3476
ZOO
5455
301587
AEPT